Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers — Stella

Home/HPV/PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

View on ClinicalTrials.gov

Recruiting

Back to HPV trials

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

Germany

University Hospital Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg

Key details

Phase

Very early testing

Sponsor

German Cancer Research Center

Collaborators

University Hospital Heidelberg, National Center for Tumor Diseases, Heidelberg

Enrollment target

~45 participants

Started

November 2022

Primary completion

December 2027

Age range

18 Years – 45 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.